Along with cannabis, the Controlled Substances Act of 1970
designated many psychedelic compounds as Schedule I controlled
substances. Schedule I controlled substances are considered to have
no legitimate medical use and their possession and sale is illegal
under U.S. federal law. Recent efforts to legalize psychedelics
have followed in the wake of legalization of medical and
recreational cannabis by multiple states. In the last two years,
Denver, Colorado, and Oakland and Santa Cruz, California,
decriminalized possession of psilocybin-containing mushrooms and/or
plants having psychedelic properties. In February 2020, the
Washington, D.C., Board of Elections decided to advance an
initiative to decriminalize possession of any plant or fungus
containing psilocybin and other psychedelic compounds. At the same
time, scientific researchers have been looking at old research in a
new light. The FDA has even shown willingness to support approval
of psychedelic therapeutics. The